Editorial
 SURVEY OF SPURIOUS DRUGS   
 Wednesday, October 29, 2014 
 The Centre has decided to conduct an all India survey on the extent of availability of spurious and not-of-standard quality drugs in the country. It is expected to be a broad-based survey covering 42,000 samples belonging to 15 therapeutic groups drawn from across the country listed in National List of Essential Medicines. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Pfizer's Pristiq clinical study shows low potential for sexual dysfunction in MDD patients
17:00  [IST]Alnylam files clinical trial application to begin phase 1 Study with ALN-PCSsc to treat hypercholesterolemia
16:30  [IST]Neuland Laboratories net up by 50% in Q2
16:20  [IST]Sanofi net moves up by 9% to € 2.7 bn in Q3
16:00  [IST]The Leukemia & Lymphoma Society begins new initiative to stop progression of myeloid blood cancers
15:00  [IST]MEI Pharma treats first patient in cohort-expansion of phase Ib clinical study-ME-344
more news >>
TOP NEWS
08:00  [IST]DCGI to approve clinical trial proposals for new drugs approved abroad, FDCs, subsequent new drugs & vaccines
08:00  [IST]Karnataka govt allots 4.31 acres land in Gulbarga for second Govt Pharmacy College
08:00  [IST]Phenomenex introduces ‘Kinetex EVO C18’ an advance analytical instrument for research labs
08:00  [IST]Diagnostic device for UTI developed by BITS Pilani - Hyderabad campus bags top honours at ABLE’s DBT’s BEST event
08:00  [IST]More research needed to find out the cause of psoriasis: INSTEAD
08:00  [IST]DCGI asks state DCs to provide data on Oxytocin to curb its illegal movement in India
more news >>
YESTERDAY'S NEWS
18:00  [IST]Boehringer Ingelheim introduces IDBS’ E-WorkBook Suite
17:15  [IST]Scottish & Indian Universities partner for drug discovery and marine biotech research-innovation
17:10  [IST]Dr Reddy's Labs net dips by 17% to Rs.574 cr in Q2
16:30  [IST]Swissmedic nod for trial on ebola vaccine
14:30  [IST]Pfizer's net income improved marginally by 2.9% in Q3
14:20  [IST]Jubilant Life Sciences net loss rises to Rs.94 cr in Q2
more news >>
INTERVIEW  
Gujarat FDCA: Playing crucial role in industry growth
Dr_H-G-Koshia.jpgDr H G Koshia, Gujarat FDCA commissioner
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |